Search This Blog

Thursday, July 18, 2019

Select Medical sees Q2 top line as high as ~$1.4B

Related to its talks with lenders about refinancing its existing debt, Select Medical Holdings (NYSE:SEM) announces certain estimates of Q2 results.
Net operating revenue: $1.360B – 1.362B.
Non-GAAP EBITDA: $185.5M – 187.0M.
It will report final Q2 results and updated guidance on Friday, August 2, before the open.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.